In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Calumet Inc (NASDAQ: CLMT) closed at $18.58 in the last session, down -0.99% from day before closing price of $18.76. In other words, the price has decreased by -$0.99 from its previous closing price. On the day, 0.65 million shares were traded. CLMT stock price reached its highest trading level at $19.05 during the session, while it also had its lowest trading level at $18.35.
Ratios:
We take a closer look at CLMT’s different ratios to gain a better understanding of. The Stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.45 and its Current Ratio is at 0.76.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The Stock’s future direction. In the most recent recommendation for this company, BofA Securities on May 13, 2025, initiated with a Buy rating and assigned. The Stock a target price of $15.
On March 17, 2025, UBS Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $15 to $12. TD Cowen Downgraded its Buy to Hold on March 04, 2025, whereas the target price for. The Stock was revised from $26 to $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 01 ’25 when DANIEL J SAJKOWSKI 2011 TRUST bought 2,000 shares for $15.76 per share.
Morical Gregory J sold 25,123 shares of CLMT for $419,303 on Jun 16 ’25. The SVP, GENERAL COUNSEL now owns 39,415 shares after completing the transaction at $16.69 per share. On Jun 16 ’25, another insider, Straumins Jennifer, who serves as the Director of the company, sold 100,000 shares for $16.23 each. As a result, the insider received 1,623,000 and left with 934,589 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLMT now has a Market Capitalization of 1611856512 and an Enterprise Value of 4314756608. For. The Stock, the TTM Price-to-Sale (P/S) ratio is 0.40. Its current Enterprise Value per Revenue stands at 1.06 whereas that against EBITDA is -178.296.
Stock Price History:
The Beta on a monthly basis for CLMT is 0.97, which has changed by 0.03222227 over the last 52 weeks, in comparison to a change of 0.16298151 over the same period for the S&P500. Over the past 52 weeks, CLMT has reached a high of $25.29, while it has fallen to a 52-week low of $7.68. The 50-Day Moving Average of. The Stock is 15.19%, while the 200-Day Moving Average is calculated to be 19.63%.
Shares Statistics:
According to the various share statistics, CLMT traded on average about 1.02M shares per day over the past 3-months and 911120 shares per day over the past 10 days. A total of 86.66M shares are outstanding, with a floating share count of 67.26M. Insiders hold about 20.21% of the company’s shares, while institutions hold 51.28% stake in the company. Shares short for CLMT as of 1756425600 were 10036435 with a Short Ratio of 9.85, compared to 1753920000 on 9678145. Therefore, it implies a Short% of Shares Outstanding of 10036435 and a Short% of Float of 14.63.
Earnings Estimates
The performance of Calumet Inc (CLMT) in. The Stock market is under the watchful eye of 5.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.13 and low estimates of -$0.35.
Analysts are recommending an EPS of between -$1.68 and -$4.04 for the fiscal current year, implying an average EPS of -$2.86. EPS for the following year is $0.57, with 2.0 analysts recommending between $0.63 and $0.51.
Revenue Estimates
According to 6 analysts, the current quarter’s revenue is expected to be $1.06B. It ranges from a high estimate of $1.25B to a low estimate of $826.6M. As of the current estimate, Calumet Inc’s year-ago sales were $1.1BFor the next quarter, 6 analysts are estimating revenue of $1.07B. There is a high estimate of $1.25B for the next quarter, whereas the lowest estimate is $790.2M.
A total of 6 analysts have provided revenue estimates for CLMT’s current fiscal year. The highest revenue estimate was $4.52B, while the lowest revenue estimate was $3.64B, resulting in an average revenue estimate of $4.15B. In the same quarter a year ago, actual revenue was $4.19BBased on 6 analysts’ estimates, the company’s revenue will be $4.28B in the next fiscal year. The high estimate is $5.05B and the low estimate is $3.14B.
